EGFR and neoplasm: However, results from individual studies are variable, with many indicating that detection of EGFR mutations in ctDNA is more difficult in plasma samples than in tumor tissue, with an average sensitivity of 65–70% (see Table 1 for definition of concordance parameters) [25].